3D Printing in Neurosurgery: An In-House Shift and ASEAN Implications

The Rise of In-House 3D Printing in European Neurosurgery Departments \nA recent study published in the International Journal of Bioprinting highlights a significant shift in the use of 3D printing within European neurosurgical departments. Between 2020 and 2025, there was a notable move towards in-house 3D printing, with a growing number of hospitals taking control of their 3D printing needs. This trend is not just a matter of convenience; it reflects a deeper integration of 3D printing into clinical workflows and the increasing importance of this technology in medical applications.\n \\[...]\\\n## What This Means for ASEAN Factories \\nFor factories in Thailand, Vietnam, Indonesia, and Malaysia, this shift towards in-house 3D printing in Europe offers valuable insights. As these countries continue to develop their healthcare infrastructure, the demand for advanced medical technologies, including 3D printing, is likely to grow. ASEAN manufacturers can capitalize on this trend by investing in 3D printing capabilities and collaborating with local hospitals and research institutions. By doing so, they can position themselves as key players in the region's growing medical technology sector. \\nAdditionally, the diversification of 3D printing technologies, such as selective laser sintering and multi-jet modeling, suggests that ASEAN factories need to stay ahead of the curve. Investing in a range of 3D printing technologies will not only meet the current demand but also prepare for future innovations. \\n## Quality Management and Institutional Support \\nDespite the growing adoption of in-house 3D printing, the study also highlights the need for robust quality management systems. As 3D printing moves from anatomical models to implant fabrication, the importance of accuracy, biocompatibility, and regulatory compliance cannot be overstated. ASEAN factories must ensure that they have the necessary quality assurance processes in place to meet these stringent requirements. \\nFurthermore, institutional support remains a critical factor. Time constraints, insufficient funding, and lack of expertise were identified as major barriers to broader implementation. For ASEAN factories, this means that collaboration with local universities, research institutions, and government bodies is essential. These partnerships can provide the necessary expertise, funding, and regulatory guidance to overcome these challenges. \\n## Conclusion \\nThe shift towards in-house 3D printing in European neurosurgical departments is a clear indicator of the technology's growing importance in medical applications. For ASEAN factories, this trend presents both opportunities and challenges. By investing in 3D printing capabilities, diversifying their technological portfolio, and ensuring robust quality management, ASEAN manufacturers can position themselves at the forefront of the region's medical technology sector. Collaboration with local institutions and government bodies will be key to overcoming the barriers and fully realizing the potential of 3D printing in healthcare. \\n**Takeaway for Factory Buyers:** Invest in 3D printing technologies, focus on quality management, and build strong partnerships with local institutions to capitalize on the growing demand for advanced medical solutions in ASEAN.